ARTELO BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.3 USD | -5.49% |
|
-3.12% | -7.14% |
Chart calendar Artelo Biosciences, Inc.
fec6.A2iV4taPxtJfnh0lLGj-HHIjabemEUiTAE1Zemy47F4.SgDc1LrViII2wWRQVCqoUihhJ93SU3ygMj4QTTn7jQd5Oe3QjryW6x3Ocg~aca4d4bf8f47a22b0388e235707bcea4
Upcoming events on Artelo Biosciences, Inc.
Past events on Artelo Biosciences, Inc.
| 23/04/2024 08:20 pm | Benzinga All Access Conference |
| 25/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 11/03/2024 | American Academy of Dermatology Meeting |
| 21/02/2024 12:30 am | Winter Wrap-Up MicroCap Rodeo Virtual Investor Conference |
| 05/12/2023 | International Medical Cannabis Conference |
| 13/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 11/10/2023 09:30 pm | Investor Meeting - H.C. Wainwright |
| 20/09/2023 04:00 pm | European Pain Federation Congress |
| 13/09/2023 11:30 pm | H.C. Wainwright Global Investment Conference |
| 12/09/2023 11:15 pm | Cannabinoid-Derived Drug Development Summit |
| 10/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 11/07/2023 08:30 pm | Benzinga All Access Event |
| 30/06/2023 08:30 pm | Annual General Meeting |
| 25/06/2023 06:45 pm | International Cannabinoid Research Society Symposium |
| 31/03/2023 05:30 pm | Q4 2022 Earnings Release |
| 22/02/2023 07:30 pm | MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conference |
| 02/02/2023 11:30 pm | Sequire Biotechnology Conference |
| 12/11/2022 | Society for Immunotherapy of Cancer Meeting |
| 08/11/2022 06:30 pm | Q3 2022 Earnings Release |
| 26/10/2022 02:00 am | LD Micro Main Event Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -5,91 -6,80 13.09% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -3,21 -3,93 18.31% | -4,69 -6,47 27.53% | -7,44 -7,96 6.51% | -10,3 -9,31 -10.51% | -9,93 -9,19 -8.01% | -14,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,17 -3,00 27.57% | -4,65 -6,44 27.66% | -7,44 -7,96 6.53% | -10,1 -6,83 -47.66% | -9,29 -8,71 -6.64% | -14,4 |
|
Net income Million USD | Released Forecast Spread | -2,17 -3,00 27.57% | -4,65 -6,44 27.66% | -7,44 -7,96 6.53% | -10,1 -9,23 -9.26% | -9,29 -8,71 -6.64% | -14,4 |
|
EPS USD | Released Forecast Spread | -15,0 -19,9 24.81% | -18,9 -24,7 23.64% | -6,00 -6,50 7.69% | -3,56 -3,04 -16.98% | -3,14 -2,56 -22.82% | -2,07 |
| Announcement Date | 25/11/19 | 04/11/20 | 29/11/21 | 31/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -1,89 -2,42 22.13% | -2,47 -2,45 -0.82% | -2,39 -2,61 8.17% | -3,48 -2,50 -39.02% | -2,29 -3,69 37.9% | -1,78 -2,88 38.14% | -2,61 -2,04 -28.1% | -3,24 -2,50 -29.62% | -3,41 | -3,56 | -3,66 | -3,82 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,89 -2,42 22.13% | -2,45 -2,45 0.07% | -2,33 -2,61 10.61% | -3,34 -2,50 -33.45% | -2,17 -3,69 41.3% | -1,60 -2,88 44.56% | -2,45 -2,04 -20.01% | -3,07 -2,50 -22.94% | -3,41 | -3,56 | -3,66 | -3,82 | |
|
Net income Million USD | Released Forecast Spread | -1,89 -2,42 22.13% | -1,97 | -2,45 -2,45 0.07% | -2,33 -2,61 10.61% | -3,34 -2,50 -33.45% | -2,17 -3,69 41.3% | -1,60 -2,88 44.56% | -2,45 -2,04 -20.01% | -3,07 -2,50 -22.94% | -3,41 | -3,56 | -3,66 | -3,82 |
|
EPS USD | Released Forecast Spread | -1,05 -1,45 27.59% | -0,75 | -0,90 -0,85 -5.88% | -0,82 -0,91 10.22% | -1,18 -0,73 -61.64% | -0,76 -1,09 30.06% | -0,56 -0,82 31.29% | -0,83 -0,65 -28.35% | -0,99 -0,56 -77.84% | -1,06 | -0,74 | -0,57 | -0,32 |
| Announcement Date | 29/11/21 | 12/05/22 | 09/08/22 | 08/11/22 | 31/03/23 | 11/05/23 | 10/08/23 | 13/11/23 | 25/03/24 | - | - | - | - |
| Today 03:30 pm | AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| Today 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 06/05/2024 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Artelo Biosciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ARTL Stock
- Calendar Artelo Biosciences, Inc.
